Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 31, Issue 3, 2008, Pages 585-591

  Thomeer, M ^a,b   Demedts, M ^a   Behr, J ^c,c   Buhl, R ^d   Costabel, U ^e   Flower, C D R ^f   Verschakelen, J ^a   Laurent, F ^h   Nicholson, A G ^g   Verbeken, E K ^a   Capron, F ⁱ   Sardina, M ^j   Corvasce, G ^j   Lankhorst, I ^j   Dekhuijzen, R ^k   Jansen, H M ^l   MacNee, W ^m   Wallaert, B ⁿ  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e RUHRLANDKLINIK   (Germany)

^f Evelyn Hospital   (United Kingdom)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j Zambon Group SpA   (Italy)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Idiopathic pulmonary fibrosis; Kappa coefficient; Lung biopsy; Radiology

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; PLACEBO; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; OPEN LUNG BIOPSY; PRIORITY JOURNAL; THORACOSCOPY; ADOLESCENT; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; EUROPE; LUNG; LUNG FIBROSIS; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; BIOPSY; EUROPE; HUMANS; LUNG; MIDDLE AGED; OBSERVER VARIATION; PULMONARY FIBROSIS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42949087510     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00063706     Document Type: Article

References (22)

1. Idiopathic pulmonary fibrosis, diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
2. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
3. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143-148.
4. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19: 275-283.
5. Tung KT, Wells AU, Rubens MB, Kirk JM, du Bois RM, Hansell DM. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993; 48: 334-338.
6. Lynch DA, Newell JD, Logan PM, King TE Jr, Müller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165: 807-811.
7. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-196.
8. Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994; 49: 236-240.
9. MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600-605.
10. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991; 179: 123-132.
11. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171: 111-116.
12. Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500-505.
13. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353: 2229-2242.
14. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: 1491-1494.
15. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 173-177.
16. Cherniack RM, Colby TV, Flint A, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1991; 144: 892-900.
17. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: 2213-2217.
18. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-1727.
19. Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol 1993; 161: 1159-1165.
20. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997; 169: 977-983.
21. Aziz ZA, Wells AU, Hansell DM, et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506-511.
22. Thomeer M. External validity of randomised controlled trials in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27: 1072.